Abstract
Background
The relationship between frailty and nocturnal voiding is poorly understood.
Aim
To characterize the association between frailty, as defined by a frailty index (FI) based upon the Canadian Study of Health and Aging (CSHA) criteria, and nocturia, defined by measures of nocturnal urine production.
Methods
Real-world retrospective analysis of voiding diaries from elderly males with lower urinary tract symptoms (LUTS) at an outpatient urology clinic. Males ≥ 65 years with ≥ 2 nocturnal voids were included. A modified FI was calculated from the LUTS database, which captured 39 variables from the original CSHA FI. Patients were divided into 3 groups by modified FI: low (≤ 0.077) (n = 59), intermediate (> 0.077 and < 0.179) (n = 58), and high (≥ 0.179) (n = 41). Diary parameters were compared using the Kruskal–Wallis test and pairwise comparisons with the Wilcoxon rank-sum test and Bonferroni adjustment.
Results
The high frailty group was characterized by higher nocturnal urine volume (NUV), maximum voided volume (MVV), nocturnal maximum voided volume (NMVV), and nocturnal urine production (NUP). The presence of comorbid diabetes mellitus did not explain this effect.
Conclusion
Elderly males seeking treatment for LUTS with a high frailty burden are disproportionately affected by excess nocturnal urine production. Future research on the mechanistic relationship between urine production and functional impairment is warranted.
Similar content being viewed by others
Change history
02 January 2020
In the original publication of the article, the author’s name Jeffrey P. Weiss was misspelled as “Jeffry P. Weiss”.
References
Cornu JN, Abrams P, Chapple CR et al (2012) A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management—a systematic review and meta-analysis. Eur Urol 62:877–890
Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. Sci World J 1:323–336
Song X, Mitnitski A, Rockwood K (2010) Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 58:681–687
Rockwood K, Song X, MacKnight C et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173:489–495
Dent E, Kowal P, Hoogendijk EO (2016) Frailty measurement in research and clinical practice: a review. Eur J Intern Med 31:3–10
Cesari M, Gambassi G, Van Kan GA et al (2014) The frailty phenotype and the frailty index: different instruments for different purposes. Age Aging 43:10–12
Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci 56A:M146–M156
Pritchard JM, Kennedy CC, Karampatos S et al (2017) Measuring frailty in clinical practice: a comparison of physical frailty assessment methods in a geriatric out-patient clinic. BMC Geriatr 17:264
Everaert K, Hervé F, Bosch R et al (2019) International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourol Urodyn 38:478–498
Grünfeld JP, Rossier BC (2009) Lithium nephrotoxicity revisited. Nat Rev Nephrol 5:270–276
van Kerrebroeck P, Abrams P, Chaikin D (2002) The standardisation of terminology in nocturia: report from the Standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178
Jones D, Song X, Mitnitski A et al (2005) Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians. Aging Clin Exp Res 17:465–471
Morley JE (2008) Diabetes, sarcopenia, and frailty. Clin Geriatr Med 24:455–469
Sinclair AJ, Abdelhafiz A, Dunning T et al (2018) An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017. J Frailty Aging 7:10–20
Bouillon K, Kivimaki M, Hamer M et al (2013) Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study. J Am Med Dir Assoc 14:851e1–851e6
Chhetri JK, Zheng Z, Xu X et al (2017) The prevalence and incidence of frailty in pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr 17:47
Pollack LR, Litwack-Harrison S, Cawthon PM et al (2017) Patterns and predictors of frailty transitions in older men: the Osteoporotic Fractures in Men Study. J Am Geriatr Soc 65:2473–2479
Zaslavsky O, Walker RL, Crane PK et al (2016) Glucose levels and risk for frailty. J Gerontol A Biol Sci Med Sci 71:1223–1229
Swedberg K, Cleland J, Dargie H et al (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140
Waldréus N, Sjöstrand F, Hahn RG (2011) Thirst in the elderly with and without heart failure. Arch Gerontol Geriatr 53:174–178
Park K, Yu M (2016) Frailty and its related factors in vulnerable elderly population by age groups. J Korean Acad Nurs 46:848–857
Suskind AM, Quanstrom K, Zhao S (2017) Overactive bladder is strongly associated with frailty in older individuals. Urology 106:26–31
Jang IY, Lee CK, Jung HW et al (2018) Urologic symptoms and burden of frailty and geriatric conditions in older men: the Aging Study of PyeongChang Rural Area. Clin Interv Aging 13:297–304
Townsley CA, Selby R, Siu LL (2005) Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 23:3112–3124
Suskind AM (2017) Frailty and lower urinary tract symptoms. Curr Urol Rep 18:67
Thom DH, Haan MN, Van Den Eeden SK (1997) Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing 26:367–374
Liao CH, Kuo HC (2013) Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity. J Urol 189:1804–1810
Suskind AM, Walter LC, Jin C et al (2016) Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database. BJU Int 117:836–842
Suskind AM, Jin C, Cooperberg MR et al (2016) Preoperative frailty is associated with discharge to skilled or assisted living facilities after urologic procedures of varying complexity. Urology 97:25–32
van Doorn B, Blanker MH, Kok ET et al (2013) Prevalence, incidence, and resolution of nocturnal polyuria in a longitudinal community-based study in older men: the Krimpen study. Eur Urol 63:542–547
Endeshaw YW, Unruh ML, Kutner M et al (2009) Sleep-disordered breathing and frailty in the Cardiovascular Health Study cohort. Am J Epidemiol 170:193–202
Wagg A, Gibson W, Johnson T 3rd et al (2015) Urinary incontinence in frail elderly persons: report from the 5th International Consultation on Incontinence. Neurourol Urodyn 34:398–406
Rockwood K, Mitnitski A (2012) How might deficit accumulation give rise to frailty? J Frailty Aging 1:8–12
George EM, Burke WM, Hou JY et al (2016) Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynaecological surgery. BJOG 123:455–461
Hoover M, Rotermann M, Sanmartin C et al (2013) Validation of an index to estimate the prevalence of frailty among community-dwelling seniors. Health Rep 24:10–17
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Thomas F. Monaghan has no direct or indirect commercial incentive associated with publishing this article and certifies that all conflicts of interest relevant to the subject matter discussed in the manuscript are the following: Adrian S. Wagg has received financial support from Astellas Pharma, Essity Health & Hygiene AB, Ferring, Pierre Fabre and Pfizer Corp outside the submitted work. Dr. Bliwise has served as a consultant for Merck, Jazz, Ferring, Eisai, and Respicardia and speaker for Merck within the last three years, outside the submitted work. Dr. Haddad reports grants from Fonds de dotation Renaitre and from Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi Périnéologie, during the conduct of the study; personal fees and non-financial support from Astellas, personal fees from MedDay Pharmaceuticals and from Novartis Pharma SAS, non-financial support from Dentsply Sirona France, Pierre Fabre Medicament, Allergan France, Bayer HealthCare SAS and Vifor France SA, outside the submitted work. Karel Everaert is a consultant and lecturer for Medtronic and Ferring and reports institutional grants from Allergan, Ferring, Astellas, and Medtronic, outside the submitted work. Jeffrey Weiss is a consultant for Ferring, and the Institute for Bladder and Prostate Research, outside the submitted work. 5 additional authors have nothing to disclose.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. A nocturnal voiding database was compiled for retrospective analysis upon approval from the Veterans Affairs New York Harbor Healthcare System Institutional Review Board.
Informed consent
A waiver of informed consent was granted for retrospective analysis.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised: The original publication of the article, the author’s name Jeffrey P. Weiss was misspelled as “Jeffry P. Weiss”.
Rights and permissions
About this article
Cite this article
Monaghan, T.F., Wagg, A.S., Bliwise, D.L. et al. Association between nocturia and frailty among elderly males in a veterans administration population. Aging Clin Exp Res 32, 1993–2000 (2020). https://doi.org/10.1007/s40520-019-01416-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-019-01416-y